Peptidylarginine deiminase IV (PADI4) is not essential for cell-autonomous HSC maintenance and normal haematopoiesis (2021)
Attributed to:
Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.13.439513
Publication URI: http://dx.doi.org/10.1101/2021.04.13.439513
Type: Preprint